HomeBusinessHealthcareProthena (PRTA) Rallies Along With Biogen (BIIB)
Prothena (PRTA) Rallies Along With Biogen (BIIB)

Prothena (PRTA) stock price today was up over 87%. Prothena is a late-stage clinical company engaged in the protein dysregulation. Their pipeline includes Parkinson's disease and Alzheimer's therapies. The PRTA stock was upgraded following positive data from Biogen (BIIB). George Tsilis weighs in on the BOFA analyst note that stated Prothena trial result is a big milestone in the treatment of Alzheimer's disease.

Market On Close

28 Sep 2022

ON AIR
1:00 pm
The Watch List
12:00 am
Fast Market
REPLAY
1:00 am
Trading 360
REPLAY
2:00 am
Next Gen Investing
REPLAY
education
3:00 am
Your First Trade
REPLAY
3:30 am
Trading 360
REPLAY
4:30 am
Next Gen Investing
REPLAY
education
5:30 am
Your First Trade
REPLAY
6:00 am
Fast Market
REPLAY
7:00 am
Futures
8:00 am
Morning Trade Live
10:00 am
Trading 360
11:00 am
Fast Market
12:00 pm
Next Gen Investing
ON AIR
1:00 pm
The Watch List
2:00 pm
Market On Close
education
3:30 pm
Your First Trade
4:00 pm
Trading 360
REPLAY
5:00 pm
Fast Market
REPLAY
6:00 pm
Next Gen Investing
REPLAY
education
7:00 pm
Your First Trade
REPLAY
7:30 pm
Trading 360
REPLAY
8:30 pm
Fast Market
REPLAY
9:30 pm
Next Gen Investing
REPLAY
education
10:30 pm
Your First Trade
REPLAY
11:00 pm
Trading 360
REPLAY

Get Market Minute

Daily insights for every investor

FOLLOW US